[1] Vinik, AI, Chaya, C. Clinical presentation and diagnosis of neuroendocrine tumors. Hematology/Oncology Clinics of North America, 2016, 30: 21-48.
[2] Hijioka M, Ito T, Igarashi H, et al. Serum chromogranin A is a useful marker for Japanese patients with pancreatic neuroendocrine tumors. Cancer Sci, 2014, 105: 1464-1471.
[3] Massironi S, Rossi R E, Casazza G, et al. Chromogranin A in diagnosing and monitoring patients with gastroenteropancreatic neuroendocrine neoplasms: a large series from a single institution. Neuroendocrinology, 2014, 100: 240-249.
[4] Liu J, Luo J, Bian J, et al. MRI findings of primary hepatic neuroendocrine tumors: correlation with pathology. Chin J Magn Reson Imaging, 2017, 8: 343-348. |
